CRISIL Research has assigned a CRISIL IER fundamental grade of ‘3/5’ to Omkar Speciality Chemicals. The grade indicates that the company’s fundamentals are ‘good’ relative to other listed equity securities in India. The rating agency has also assigned a valuation grade of ‘5/5’ to the company.
The fundamental grade factors in the company’s established position in pharma intermediates and the specialty chemicals industry. The company derives 70% of its revenues from pharma intermediates and the balance from specialty chemicals.
Omkar Speciality manufactures pharmaceutical intermediaries and specialty chemicals. The company has a diverse portfolio of over 80 products, both organic and inorganic compounds. These compounds are used in a wide range of industries like pharmaceutical, glass, agrochemicals, poultry, paints and dyes, electroplating, textiles, cosmetics and ceramic. The company has three manufacturing units in Thane district, Maharashtra and plans to set up a fourth one in the same area.
| Company Name | CMP |
|---|---|
| BASF India | 3693.20 |
| Tata Chemicals | 707.70 |
| SRF | 2474.05 |
| Pidilite Inds. | 1407.65 |
| Deepak Nitrite | 1645.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: